dc.date.accessioned | 2022-01-18T19:34:43Z | |
dc.date.available | 2022-01-18T19:34:43Z | |
dc.date.created | 2022-01-18T19:34:43Z | |
dc.date.issued | 2011 | |
dc.identifier | https://hdl.handle.net/20.500.12866/11191 | |
dc.identifier | https://doi.org/10.1645/GE-2420.1 | |
dc.description.abstract | We have evaluated the possible mechanisms of liver fibrosis caused by Fasciola hepatica in an animal model and in culture using immortalized human stellate cells. Liver biopsies of F. hepatica-infected rats were performed at wk 8 and 16. Serum-starved LX-2 cells, a human stellate cell line, were exposed to increasing concentrations of Fas2 antigen. The expression of key fibrosis-related genes was evaluated by qRT-PCR. There was a significant correlation between fibrogenic gene expression and both intensity and duration of infection. LX-2 cells exposed to Fas2 showed progressively increased expression of mRNAs for Collagen I, alpha-smooth muscle-actin, platelet-derived growth factor beta receptor, and tissue inhibitor of metalloproteinase II; inhibition of Fas2 cysteine proteinase activity by E-64 abrogated these increases, suggesting that the protease activity of Fas2 is involved in fibrogenic stimulation. In summary, F. hepatica infection is associated with up-regulation of mRNAs associated with hepatic fibrogenesis in vivo and in activated hepatic stellate cells. | |
dc.language | eng | |
dc.publisher | American Society of Parasitologists | |
dc.relation | Journal of Parasitology | |
dc.relation | 1937-2345 | |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Humans|controlled study | |
dc.subject | pathology | |
dc.subject | animal | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Animals | |
dc.subject | collagen type 1 | |
dc.subject | genetics | |
dc.subject | in vitro study | |
dc.subject | in vivo study | |
dc.subject | metabolism | |
dc.subject | non|physiology | |
dc.subject | pathogenicity | |
dc.subject | polymerase chain reaction | |
dc.subject | infectious disease | |
dc.subject | parasite antigen | |
dc.subject | unclassified drug | |
dc.subject | disease association | |
dc.subject | gene expression | |
dc.subject | Disease Models, Animal | |
dc.subject | Analysis of Variance | |
dc.subject | Cell Line | |
dc.subject | messenger RNA | |
dc.subject | upregulation | |
dc.subject | disease model | |
dc.subject | real time polymerase chain reaction | |
dc.subject | enzymology | |
dc.subject | tissue inhibitor of metalloproteinase 1 | |
dc.subject | Fasciola hepatica | |
dc.subject | Fascioliasis | |
dc.subject | enzyme activity | |
dc.subject | Animalia | |
dc.subject | Antigens, Helminth | |
dc.subject | cysteine proteinase | |
dc.subject | Rats | |
dc.subject | analysis of variance | |
dc.subject | Gene Expression | |
dc.subject | functional morphology | |
dc.subject | genetic analysis | |
dc.subject | numerical model | |
dc.subject | gelatinase A | |
dc.subject | experimental study | |
dc.subject | transforming growth factor beta1 | |
dc.subject | Rattus | |
dc.subject | Actins | |
dc.subject | alpha smooth muscle actin | |
dc.subject | antigen | |
dc.subject | cell activation | |
dc.subject | cell organelle | |
dc.subject | Collagen | |
dc.subject | Cysteine Endopeptidases | |
dc.subject | Fas antigen | |
dc.subject | Fas2 antigen | |
dc.subject | Fas2 antigen, Fasciola hepatica | |
dc.subject | fibrogenesis | |
dc.subject | flatworm | |
dc.subject | Hepatic Stellate Cells | |
dc.subject | inhibitor | |
dc.subject | liver biopsy | |
dc.subject | Liver Cirrhosis | |
dc.subject | liver fibrosis | |
dc.subject | n [n (3 carboxyoxirane 2 carbonyl)leucyl]agmatine | |
dc.subject | platelet derived growth factor beta receptor | |
dc.subject | Receptor, Platelet-Derived Growth Factor beta | |
dc.subject | stellate cell | |
dc.subject | tissue inhibitor of metalloproteinase 2 | |
dc.subject | Tissue Inhibitor of Metalloproteinase-2 | |
dc.title | Mechanisms of liver fibrosis associated with experimental fasciola hepatica infection: Roles of Fas2 proteinase and hepatic stellate cell activation | |
dc.type | info:eu-repo/semantics/article | |